Strategic recommendations from the STARS project to foster academic drug development-Reference-Cited by-同舟云学术

Strategic recommendations from the STARS project to foster academic drug development

Published:2023-02-08 Issue:4 Volume:22 Page:251-252
ISSN:1474-1776
Container-title:Nature Reviews Drug Discovery
language:en
Short-container-title:Nat Rev Drug Discov

Author:

Starokozhko Viktoriia,Heß Anne,Löbker Wiebke,Ballensiefen Wolfgang,Agricola Eleonora,Ziegele Bettina,Kallio Marko J.,O’Dwyer Laurence,Nuevo Yoana,Mol Peter G. M.,Pasmooij Anna M. G.

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.nature.com/articles/d41573-023-00021-z.pdf

Reference5 articles.

1. de Wilde, S., Guchelaar, H.J., Zandvliet, M.L. & Meij., P. Clinical development of gene- and cell-based therapies: overview of the European landscape. Mol. Ther. Methods Clin. Dev. 3, 16073 (2016).

2. Kinch, M.S., Horn, C., Kraft, Z. & Schwartz, T. Rising academic contributions to drug development: evidence of vigor or trauma? ACS Pharmacol. Transl. Sci. 3, 1427−1429 (2020).

3. Gilliland, C. T., et al. Putting translational science on to a global stage. Nat. Rev. Drug Discov. 15, 217–218 (2016).

4. Starokozhko, V. et al. STARS consortium. Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap. Drug Discov. Today 26, 283–288 (2021).

5. Kallio, M. J. et al. Translating academic drug discovery into clinical development: a survey of the awareness of regulatory support and requirements among stakeholders in Europe. Clin. Pharmacol. Ther. 113, 349–359 (2023).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A roadmap towards a human-centric safety assessment of advanced therapy medicinal products;Regulatory Toxicology and Pharmacology;2024-06

2. The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report;Clinical Pharmacology & Therapeutics;2024-04-28

3. The European Innovation Network as a hub for medicines innovation in Europe;Nature Reviews Drug Discovery;2024-03-11

4. Academic challenges on advanced therapy medicinal products’ development: a regulatory perspective;Cytotherapy;2024-03